SARS-CoV-2 rapid diagnostic testing: Canadian consensus guidance for pharmacists
Can Pharm J (Ott)
.
2023 Apr 19;156(3):128-136.
doi: 10.1177/17151635231164631.
eCollection 2023 May-Jun.
Authors
Aaron Sihota
1
,
Brett Barrett
2
,
Cameron Bonell
3
,
Ahmad Chehade
4
,
Jerry Dhaliwal
5
,
Michael Kani
6
,
Jamie Kellar
7
,
Conny Kwong
8
,
Pavithra Ravinatarajan
9
,
Kevin L Schwartz
10
11
,
Stacey Smith
12
,
Jean Thiffault
13
,
Cassandra Woit
14
,
Alon Vaisman
15
16
Affiliations
1
Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia.
2
School of Pharmacy, University of Waterloo and Grand River Hospital, Kitchener, Ontario.
3
Interior Health Authority and Faculty of Pharmaceutical Sciences, University of British Columbia, Kelowna, British Columbia.
4
Upharmacy, Edmonton, Alberta.
5
London Drugs, Surrey, British Columbia.
6
Langham Pharmacy, Langham, Saskatchewan.
7
Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario.
8
Rexall Pharmacy Group Ltd., Winnipeg, Manitoba.
9
Pavithra Consulting Inc., Ontario.
10
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario.
11
Division of Infectious Diseases, Unity Health Toronto, St. Joseph's Health Centre, Toronto, Ontario.
12
Consultant Pharmacist, Dartmouth, Nova Scotia.
13
Pharmacie Jean Coutu, Montréal, Québec.
14
North Central CO-OP Pharmacy, Edmonton, Alberta.
15
Department of Medicine, University of Toronto, Toronto, Ontario.
16
Division of Infectious Diseases, University Health Network, Toronto, Ontario.
PMID:
37197090
PMCID:
PMC10116221
DOI:
10.1177/17151635231164631
No abstract available